Prognostic and therapeutic aspects;Pronostic et problemes therapeutiques

Presse Medicale

Volumn 27, Issue 13, 1998, Pages 638-640

  Modigliani, E ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; ENDOCRINE TUMOR; HUMAN; LYMPH NODE DISSECTION; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; PROGNOSIS; REVIEW; THYROID CARCINOMA; THYROIDECTOMY; AGE; ARTICLE; CHILD; CLASSIFICATION; FOLLOW UP; GENETICS; HYPERPARATHYROIDISM; INFANT; MALE; PRESCHOOL CHILD; RISK FACTOR; SEX DIFFERENCE; THYROID TUMOR;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; ENDOCRINE GLAND NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; INFANT; MALE; PHEOCHROMOCYTOMA; PROGNOSIS; RISK FACTORS; SEX FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0032481886     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Modigliani E, Vasen HFA, Raue K et al. Pheochromocytoma in multiple endocrine neoplasia type 2: European study. J Intern Med 1995 ; 238:363-7.
2. Evans DB, Lee JE, Merrell RC, Hickey RC. Adrenal medullary disease in multiple endocrine neoplasia type 2; appropriate management. Endocr Metab Clin North Am 1994 ; 23:167-76.
3. Dralle H, Shurmeyer T, Kozerke T et al. Surgical aspects of familial pheochromocytoma. Horm Metab Res 1989 ; suppl 21:34-8
4. Casanova S, Rosenberg-Bourgin M, Farkas D C et al. Pheochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clin Endocrinol 1993 ; 38:531-7.
5. Kraimps JL, Denisot A, Carnaille B et al. Primary hyperparathyroidism in multiple endocrine neoplasia type 2A: a retrospective french multicentric study. Word J Surg 1996 ; 20:808-13
6. Proye C, Marmousez T, the Association française de Chirurgie endocrinienne & the GETC. Cancer médullaire de la thyroïde : moyens thérapeutiques, chirurgie de première intention. In: Medullary thyroid carcinoma. Calmettes C and Guliana JM eds. Colloque Inserm John Libbey Eurotext 1991 ; 211:199-206.
7. Dralle H, Scheumann GFW, Proye C et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 1995 ; 238:357-61.
8. Wells SA, Chi DD, Toshima K et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994 ; 220:362-70.
9. Lips CJM, Landswater RM, Hoppener JWH et al. Clinical screening as compared with DNA analysis in families with multiple endocrine noplasia type 2A. N Engl J Med 1994 ; 331:828-35.
10. Proye C, Carnaille B, Vanhove L. Morbidité de la thyroïdectomie totale chez l'enfant et l'adolescent de moins de 15 ans. Ann Endocrinol 1998 (sous presse).
11. Murat A, Modigliani E, Conte-Devolx B et al. Prise en chage thérapeutique précoce des sujets prédisposés génétiquement au cancer médullaire du corps thyroïde. Ann Chir 1998 (sous presse).
12. Barbot N, Calmettes C, Schuffenecker I et al. Pentagastrin stimulation test and early diagnosis of medullary thyroïd carcinoma using a immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 1994 ; 78:114-20.
13. Saad MF, Ordoner NG, Rashid RK et al. Medullary carcinoma of the thyroid: a study of clinical features and prognostic factors in 161 patients. Medicine 1984 ; 63:319-42.
14. Bergholm U, Adami HO, Bergström R et al. Long term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. Acta Chir Scand 1990 ; 156:37-46.
15. Raue F, Kotzerke J, Reinwein D et al. Prognostic factors in Medullary Thyroid Carcinoma : evaluation of 741 patients from the German MTC register. Clin Invest 1993 ; 71:7-12.
16. Modigliani E, Cohen R, Campos JM et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 cases. Clin Endocrinol 1998 ; 48 (sous presse).
17. Cohen R, Buchsenschutz B, Estrade P, Gardet P, Modigliani E et le G.E.T.C. Causes de mortalité chez les patients atteints de cancer médullaire. Pr. Med 1996 ; 25:1819-22.
18. Franc B. Le cancer médullaire de la thyroïde : la place de l'anatomie pathologique face aux tests génétiques. Rev Fr Lab 1994 ; 270:27-36.
19. Franc B, Rosenberg-Bourgin M, Caillou B et al. Medullary thyroid carcinoma: search for histological predictor of survival. Hum pathol 1998 (sous presse).
20. Eng C. The RET proto-oncogene in multiple endocrine neoplasia Type 2 and Hirschprung disease. N Engl J Med 1996 ; 335:943-51.